Back to search results
NCT05932615

ENVISION IDE Trial: Safety and Effectiveness of NAVITOR in Transcatheter Aortic Valve Implantation

Enrolling by Invitation
NAAges 18+InterventionalTreatment
Abbott Medical Devices
~1,500 participants
Updated 2026-05-08 on ClinicalTrials.gov
What's tested:Navitor Transcatheter Aortic Valve Implantation (TAVI) SystemAny Commercially Available Transcatheter Aortic Valve (CAV) System

At a glance

Recruiting sites
0 of 84 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Composite of all-cause mortality or all stroke
Measured over At 12 months post-procedure

Conditions

Aortic Valve Stenosis
Heart Valve Diseases
Aortic Valve Disease
Heart Disease Structural Disorder

Explore related trials

Aortic Valve DisorderAortic Valve StenosisBioprosthetic Aortic Valve Failure

Where it's being run

84 sites across 47 states
Florida6
Texas6
California5
Michigan4
New York4
Pennsylvania4
Illinois3
Ohio3

Study leadership

  • Haresh Sachanandani · STUDY_DIRECTOR · Abbott Structural Heart
  • Michael Reardon, MD · STUDY_CHAIR · The Methodist Hospital Research Institute
  • Azeem Azeem, MD · STUDY_CHAIR · Montefiore Medical Center
  • Bassem Chehab, MD · PRINCIPAL_INVESTIGATOR · Ascension Via Christi Hospitals
  • Ibrahim Sultan, MD · PRINCIPAL_INVESTIGATOR

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

What this trial measures

  • Composite of all-cause mortality or all strokeAt 12 months post-procedure

    Number of patients that had any of the outcome events.